Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics.
PASH
breast
fibroadenoma
fibroepithelial
giant juvenile fibroadenoma
next generation sequencing
pseudoangiomatous stromal hyperplasia
Journal
Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
revised:
15
04
2023
received:
15
02
2023
accepted:
17
04
2023
medline:
11
8
2023
pubmed:
4
5
2023
entrez:
4
5
2023
Statut:
ppublish
Résumé
Juvenile fibroadenomas (JFA) are biphasic fibroepithelial lesions (FEL) usually occurring in adolescent female patients. Giant (G) JFA, like other FEL, may exhibit prominent pseudoangiomatous stromal hyperplasia (PASH)-like change. We sought to determine clinicopathological and molecular characteristics of GJFA with and without PASH. Archives were searched for cases of GJFA (1985-2020). All were stained for androgen receptor (AR), beta-catenin, CD34 and progesterone receptor (PR). Cases were sequenced using a custom 16-gene panel - MED12 (exons 1 and 2), TERT promoter (-124C>T and -146Ctable>T), SETD2, KMT2D, RARA (exons 5-9), FLNA, NF1, PIK3CA (exons 10, 11 and 21), EGFR, RB1, BCOR, TP53, PTEN, ERBB4, IGF1R and MAP3K1. Twenty-seven GJFA from 21 female patients aged 10.1-25.2 years were identified. Size ranged from 5.2 to 21 cm. Two patients had multiple, bilateral and later recurrent GJFA. Thirteen (48%) cases showed prominent PASH-like stroma. All were positive for stromal CD34, negative for AR and beta-catenin and one case showed focal PR expression. Sequencing showed MAP3K1 and SETD2 mutations in 17 samples, with KMT2D, TP53 and BCOR aberrations in 10 (45%), 10 (45%) and seven (32%) cases, respectively. Tumours with a PASH-like pattern had higher prevalence of SETD2 (P = 0.004) and TP53 (P = 0.029) mutations, while those without PASH had more RB1 mutations (P = 0.043). MED12 mutation was identified in one case. TERT promoter mutation was observed in four (18%), including two recurrences. Gene mutations along more advanced phases of the proposed FEL pathogenetic pathway in GJFA are unusual, and suggest a mechanism for more aggressive growth in these tumours.
Substances chimiques
beta Catenin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
357-365Subventions
Organisme : MCW Department of Pathology and a SingHealth Duke-NUS Pathology Academic Clinical Programme - ACP Pathology Fund
Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
BlueBooksOnline. Accessed June 12, 2022. https://tumourclassification.iarc.who.int/chaptercontent/32/51.
Jayasinghe Y, Simmons PS. Fibroadenomas in adolescence. Curr. Opin. Obstet. Gynecol. 2009; 21; 402-406.
Park CA, David LR, Argenta LC. Breast asymmetry: presentation of a giant fibroadenoma. Breast J. 2006; 12; 451-461.
Pareja F, Da Cruza PA, Murray MP et al. Recurrent MED12 exon 2 mutations in benign fibroepithelial lesions in adolescents and young adults. J. Clin. Pathol. 2019; 72; 258-262.
Tay TKY, Guan P, Loke BN et al. Molecular insights into paediatric breast fibroepithelial tumours. Histopathology 2018; 73; 809-818.
Kuijper A, Mommers ECM, van der Wall E, van Diest PJ. Histopathology of fibroadenoma of the breast. Am. J. Clin. Pathol. 2001; 115; 736-742.
Anderson C, Ricci A, Pedersen CA, Cartun RW. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Am. J. Surg. Pathol. 1991; 15; 145-149.
Bowman E, Oprea G, Okoli J et al. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J. 2012; 18; 242-247.
Powell CM, Cranor ML, Rosen PP. Pseudoaniomatous stromal hyperplasia (PASH): a mammary stromal tumor with myofibroblastic differentiation. Am. J. Surg. Pathol. 1995; 19; 270-277.
Shehata BM, Fishman I, Collings MH et al. Pseudoangiomatous stromal hyperplasia of the breast in pediatric patients: an underrecognized entity. Pediatr. Dev. Pathol. 2009; 12; 450-454.
Recavarren RA, Chivukula M, Carter G, Dabbs DJ. Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction? Int. J. Clin. Exp. Pathol. 2009; 3; 87-97.
Baker GM, Guzman-Arocho YD, Bret-Mounet VC et al. Testosterone therapy and breast histopathological features in transgender individuals. Mod. Pathol. 2021; 34; 85-94.
Babraham bioinformatics-FastQC a quality control tool for high throughput sequence data. https://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
Krueger F, James F, Ewels P et al. FelixKrueger/TrimGalore: v0.6.9-fix declaration bug. 2023 https://doi.org/10.5281/zenodo.7581188.
Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. ArXiv13033997 Q-Bio2013.
Li H, Handsaker B, Wysoker A et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25; 2078-2079.
Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. 2012. Preprint at https://doi.org/10.48550/arXiv.1207.3907.
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38; e164.
Lek M, Karczewski M, Lek M et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536; 285-291.
Auton A, Brooks LD, Durbin RM et al. A global reference for human genetic variation. Nature 2015; 526; 68-74.
Thorvaldsdóttir H, Robinson JT, Mesirov JP. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 2013; 14; 178-192.
Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002; 30; 3894-3900.
Landrum MJ, Lee JM, Benson M et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016; 44(D1); D862-D868.
Chakravarty D, Gao J, Phillips SM et al. OncoKB: a precision oncology knowledge base. JCO Precis Oncologia 2017; PO.17.00011; 1-16.
Sanchez R, Ladino-Torres MF, Bernat JA, DiPeitro MA. Breast fibroadenomas in the pediatric population: common and uncommon sonographic findings. Pediatr. Radiol. 2010; 40; 1681-1689.
Bayramoglu Z, Yilmaz R, Caliskan E, Onder S, Akkavak G, Adaletli I. Unilateral rapid enlargement of an adolescent breast: pseudoangiomatous stromal hyperplasia in a giant juvenile fibroadenoma. Breast J. 2018; 24; 648-649.
Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma. Virchows Arch. 1998; 433; 311-314.
Chang HY, Koh VCY, Md Nasir ND et al. MED12, TERT and RARA in fibroepithelial tumours of the breast. BMJ 2020; 73; 51-56.
Pareja F, Geyer FC, Kumar R et al. Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways. NJP Breast Cancer 2017; 3; 40.
Piscuoglio S, Geyer FC, Burke KA et al. Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor. NJP Breast Cancer 2016; 2; 16035.
Pham TT, Angus SP, Johnson GL. MAP3K1: genomic alterations in cancer and function in promoting cell survival or apoptosis. Genes Cancer 2013; 4; 419-426.
Tan J, Ong CK, Lim WK et al. Genomic landscapes of breast fibroepithelial tumors. Nat. Genet. 2015; 47; 1341-1345.
Md Nasir ND, Ng CCY, Rajasegaran V et al. Genomic characterization of breast fibroepithelial lesions in an international cohort. J. Pathol. 2019; 249; 447-460.
Lim WK, Ong CK, Tan J et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat. Genet. 2014; 46; 877-880.
Xie SN, Cai YJ, Ma B et al. The genomic mutation spectrums of breast fibroadenomas in Chinese population by whole exome sequencing analysis. Cancer Med. 2019; 8; 2372-2379.